Breaking News

Recipharm Invests in Lab+ Technology at Kaysersberg Facility

Bolsters its sterile filling capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Global contract development and manufacturing organization (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS) filling at its facility in Kaysersberg, France.   BFS is an automated manufacturing process where plastic ampoules are blow-formed, filled, and sealed in a continuous operation. Recipharm offers sterile BFS contract manufacturing for a range of pharmaceutical products and applications including gels, solu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters